1132935-79-5

Basic information

• Product Name: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-hydroxy-N-(4-(methylsulfonamido)phenyl)benzamide
• Synonyms: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-hydroxy-N-(4-(methylsulfonamido)phenyl)benzamide
• CAS NO: 1132935-79-5
• Molecular Weight: 474.538
• Mol File: 1132935-79-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-hydroxy-N-(4-(methylsulfonamido)phenyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-hydroxy-N-(4-(methylsulfonamido)phenyl)benzamide(1132935-79-5)
• EPA Substance Registry System: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-hydroxy-N-(4-(methylsulfonamido)phenyl)benzamide(1132935-79-5)

Safety Data

• Hazardous Substances Data: 1132935-79-5(Hazardous Substances Data)

Upstream product

• 1132941-56-0 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-hydroxy-benzoic acid 
• 57005-04-6 N-(4-aminophenyl)methanesulfonamide hydrochloride 

Relevant articles and documents

URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C

Present application relates to the compounds of formula I useful to treat hepatitis C (HCV) infections. In the structure of the disclosed compounds is the uracil or thymine derivative linked via a phenylene into either fused 2-ring cyclic system (R6) or alternatively via additional two-atom linker (L) to a 5-6 membered monocycle (R6). Application further discloses polymorphs and pseudopolymorphs of two specific compounds: N-(6(3-t-butyl-5-(2>4-dioxo-3,4-dihydropyrimidin-1 (2H)- y!)2-methoxy-phenyl)naphthalen-2-yl)methanesulfonamide and (E)-N-(4(3-t- butyl-5-(2,4-dioxo-3)4-dihydropyrimidin-1 (2H)-yl)2-methoxy-styryl- phenyl)methanesulfonamide.